(Press-News.org) Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation – a breakthrough that could lead to new treatments for chronic diseases affecting millions worldwide.
Inflammation is the body’s frontline defence against infection and injury, but when it doesn’t switch off properly, it can drive serious health conditions such as arthritis, heart disease, and diabetes. Until now, scientists didn’t fully understand how the body decides to stop the immune ‘fight’ response and start healing.
Published in Nature Communications, the study reveals that tiny fat-derived molecules called epoxy-oxylipins act as natural brakes on the immune system. These molecules prevent the overgrowth of certain immune cells, known as intermediate monocytes*, that can cause chronic inflammation – linked to tissue damage, illness and disease progression.
For the study, healthy human volunteers were given a tiny injection of UV-killed E. coli bacteria into the forearm, which triggered a short-lived inflammatory reaction – pain, redness, heat and swelling – similar to what happens after an infection or injury.
Volunteers were split into two groups: prophylactic arm and therapeutic arm.
At different times the volunteer groups were given a drug called GSK2256294, which blocks an enzyme known as soluble epoxide hydrolase (sEH), which naturally breaks down epoxy-oxylipins.
Prophylactic arm: Participants received the drug two hours before inflammation began, to see if boosting epoxy-oxylipins early could prevent harmful immune changes. In this group there were 24 volunteers – 12 were treated, 12 untreated (placebo).
Therapeutic arm: Participants received the drug four hours after inflammation started, mimicking real-world treatment once symptoms appear. In this group there were 24 volunteers – 12 were treated, 12 untreated (placebo).
Both approaches showed that blocking the enzyme sEH with GSK2256294 raised epoxy-oxylipin levels, accelerated pain resolution, and sharply reduced levels of intermediate monocytes in blood and tissue – the immune cells linked to chronic inflammation and disease. Interestingly, the drug did not significantly alter external symptoms, such as redness and swelling.
Further tests revealed that one epoxy-oxylipin, 12,13-EpOME, works by shutting down a protein signal called p38 MAPK, which drives monocyte transformation. This was confirmed in lab experiments and in volunteers given a p38-blocking drug.
First author Dr Olivia Bracken (UCL Department of Ageing, Rheumatology and Regenerative Medicine) said: “Our findings reveal a natural pathway that limits harmful immune cell expansion and helps calm inflammation more quickly.
“Targeting this mechanism could lead to safer treatments that restore immune balance without suppressing overall immunity.
“With chronic inflammation ranked as a major global health threat, this discovery opens a promising avenue for new therapies.”
Corresponding author Professor Derek Gilroy (UCL Division of Medicine) said: “This is the first study to map epoxy-oxylipin activity in humans during inflammation.
“By boosting these protective fat molecules, we could design safer treatments for diseases driven by chronic inflammation.”
He added: “This was an entirely human-based study with direct relevance to autoimmune diseases, as we used a drug already suitable for human use – one that could be repurposed to treat flares in chronic inflammatory conditions, an area currently bereft of effective therapies.”
Why epoxy-oxylipins?
Scientists chose to study epoxy-oxylipins because these fat-derived molecules were known from animal research to reduce inflammation and pain, but their role in humans remained unknown. Unlike well-studied inflammatory mediators, such as histamine and cytokines, epoxy-oxylipins are part of an underexplored pathway that scientists believed could naturally calm the immune system.
Next steps
The discovery opens the door to clinical trials exploring sEH inhibitors as potential therapies for conditions like rheumatoid arthritis and cardiovascular disease.
Dr Bracken said: "For instance, rheumatoid arthritis is a condition in which the immune system attacks the cells that line your joints. sEH inhibitors could be trialled alongside existing medications to investigate if they can help prevent or slow down joint damage incurred by the condition."
Dr Caroline Aylott, Head of Research Delivery at Arthritis UK, said: "The pain of arthritis can affect how we move, think, sleep and feel, along with our ability to spend time with loved ones. Pain is incredibly complex and is affected by many different factors. We also know that everybody's pain is different.
“That is why it is important that we invest in research like this, that helps us understand what causes and influences people's experience of pain.
“We are excited to see the results of this study which has found a natural process that could stop inflammation and pain. We hope in the future that this will lead to new pain management options for people with arthritis."
The study was funded by Arthritis UK and involved researchers at UCL, King’s College London, University of Oxford, Queen Mary University of London, and National Institute of Environmental Health Sciences, USA.
* Intermediate monocytes are white blood cells that help fight infection and repair tissue. In short bursts, they help coordinate the immune response and support recovery, but if they persist or grow in excess, they keep the immune system switched on, leading to chronic inflammation.
END
Scientists discover natural ‘brake’ that could stop harmful inflammation
2026-01-16
ELSE PRESS RELEASES FROM THIS DATE:
Tougher solid electrolyte advances long-sought lithium metal batteries
2026-01-16
A solid – rather than liquid – electrolyte between the opposite electrodes of a battery should, in theory, enable a rechargeable lithium metal battery that is safer, packs much more energy, and charges considerably faster than the lithium-ion batteries commercially available today. For decades, scientists and engineers have explored several paths to realize the great promise of lithium metal batteries. A major problem with the solid, crystalline electrolytes under study has been the formation of microscopic cracks that ...
Experts provide policy roadmap to reduce dementia risk
2026-01-16
A national panel of experts has issued the strongest call yet for the Department of Health and Social Care to overhaul how it approaches dementia prevention, pointing to vital evidence that dementia risk can be reduced and providing a framework for the development of new government policy that could improve brain health for millions.
The Nottingham Consensus, published in Nature Reviews Neurology, was led by researchers at the NIHR Policy Research Unit in Dementia and Neurodegeneration at Queen Mary University ...
New 3D imaging system could address limitations of MRI, CT and ultrasound
2026-01-16
In a proof-of-concept study funded by the National Institutes of Health, researchers from the Keck School of Medicine of USC and the California Institute of Technology (Caltech) have shown that an innovative, noninvasive technique can be used to quickly collect 3D images of the human body, from head to foot. The technology combines ultrasound and photoacoustic imaging, which detects sound waves generated by light, to simultaneously collect images of both tissue and blood vessels. The findings, just published in the journal Nature Biomedical Engineering, have the potential to address current gaps in medical imaging.
Imaging ...
First-in-human drug trial lowers high blood fats
2026-01-16
When we eat, our bodies convert extra calories, especially from carbs, sugar, fats, and alcohol, into molecules called “triglycerides”. Triglycerides are a form of fat or “lipid”, which the body stores away into its fat cells as an energy fuel for energy between meals.
But, as we all know, excess amounts of fat in the body can be dangerous, causing a condition known as “hypertriglyceridemia” (“excess triglycerides in the blood”), which significantly increases the risk of heart disease, stroke, and pancreatitis. This ...
Decades of dredging are pushing the Dutch Western Scheldt Estuary beyond its ecological limits
2026-01-16
The Dutch Western Scheldt Estuary has been pushed onto an unsustainable trajectory since large-scale navigation channel deepening began in the 1970s. The dramatic increase in the annual volume of dredged sediment from the navigation channel has reduced feeding grounds for birds and made the estuary more vulnerable to sea-level rise.
This is shown by the Dutch report De Westerscheldenatuur: Een mooie toekomst vraagt keuzes nu!. Dutch and Flemish researchers call on policymakers to use dredged sediment strategically for nature restoration and climate adaptation.
After analysing nearly seventy years of monitoring data from the Dutch water ...
A view into the innermost workings of life: First scanning electron microscope with nanomanipulator inaugurated in hesse at Goethe University
2026-01-16
FRANKFURT. With a so-called cryo plasma-FIB (Plasma Focused Ion Beam) scanning electron microscope with nanomanipulator, the Goethe University in Frankfurt (Germany) is expanding its research infrastructure with a powerful instrument. The microscope was inaugurated today at the Buchmann Institute for Molecular Life Sciences on the Riedberg Campus – as the first of its kind in Hesse and one of only a few in all of Germany.
The large-scale instrument works with a focused plasma ion beam, which can be used to prepare tiny sections from biological cells – so-called nanobiopsies with dimensions in the nanometer range. The decisive advantage ...
Simple method can enable early detection and prevention of chronic kidney disease
2026-01-16
Subtle abnormalities in kidney function – even within the range considered normal – may help identify people at risk of developing chronic kidney disease. This is shown in a new study from Karolinska Institutet, published in Kidney International. The researchers have therefore developed a web-based tool that could aid in early detection and thus primary prevention.
Chronic kidney disease is a growing global health concern afflicting 10−15 per cent of adults worldwide and is projected ...
S-species-stimulated deep reconstruction of ultra-homogeneous CuS nanosheets for efficient HMF electrooxidation
2026-01-16
RESEARCH
The massive consumption of fossil fuels in human society has led to increasingly severe resource crises and environmental pollution, and the efficient utilization of renewable biomass resources is one of the feasible approaches to addressing these issues. The electrocatalytic oxidation of 5-hydroxymethylfurfural (HMF) to produce 2,5-furandicarboxylic acid (FDCA) is expected to reduce the excessive reliance on fossil resource-derived terephthalic acid (PTA), a petroleum-based platform molecule. However, the development of high-performance and low-cost electrocatalysts for the efficient HMF oxidation ...
Mechanical and corrosion behavior of additively manufactured NiTi shape memory alloys
2026-01-16
A team from Lanzhou University of Technology have developed a novel NiTi shape memory allow (SMA) with harmonic microstructures fabricated via selective laser melting (SLM). This work explores the relationship between microstructural evolution at various deformation stages and corrosion behaviour in seawater environments. The study reveals that in its initial states, the alloy exhibits superior corrosion resistance, primarily owing to dense and stable passivation films composed mainly of TiO₂ and NiO. Post-fracture, the formation of fragmented amorphous phases and nanocrystalline grains accelerates corrosion processes. Leveraging first-principles ...
New discovery rewrites the rules of antigen presentation
2026-01-16
A new discovery about how cells communicate with each other in the body’s immune system has revealed deeper insights for an international team of scientists into fundamental immune system function.
The new study, published in Nature Communications, overturns a long held understanding about how T cells – white blood cells that make up a key part of the immune system – recognise lipid antigens, a chemical class of molecules that make up cell membranes.
Lipids are presented to T cells by a distinct family of molecules called CD1, yet one member of this family, CD1c, has remained poorly understood despite its significant role in human immunity.
For more than 30 years, ...